In conclusion, our study reveals that reduced BDNF levels in AIS patients with T2DM are associated with the formation of denser, less permeable, fibrin-rich thrombi, which may contribute to thrombolysis resistance and worse stroke outcomes. The gene discussed is BDNF; the disease is stroke disorder.